The Good, the Bad, and the Best Jobs - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Good, the Bad, and the Best Jobs
Readers provide insight into the best companies to work for as well as the ups and downs of their jobs.

Pharmaceutical Technology
Volume 32, Issue 12, pp. 74-73

This month's "Viewpoint" column is attributed to the nearly 1200 industry participants who responded to our annual employment survey (see full coverage on "Is Job Security Throwing You Off Balance?"). Since 1988, the survey has provided a comprehensive look into the workforce of one of the world's largest industries: pharmaceuticals.

Best companies to work for

The questionnaire provided participants an opportunity to nominate their employer as one of the industry's "Best Companies to Work For." More than 250 employers were nominated by at least one employee. Nominations were evaluated according to employee benefits, employee attitudes toward their jobs, opportunity for professional advancement and raises, scientific challenge and problem-solving opportunities, communication among coworkers, and management's understanding of and communication to personnel of the company's goals .

Based on these criteria, the best pharmaceutical employers are:
  • Abbott Laboratories (North Chicago, IL). Abbott provides job satisfaction through valuable benefits and flexible work hours.
  • Covance (Madison, WI). Covance employees report good opportunities for scientific challenges, a positive work environment, and the firm's appreciation of diversity.
  • Genzyme (Cambridge, MA). Employees report high precentage of job security thanks to company growth and expanding research.
  • Eli Lilly (Indianapolis, IN). Eli Lilly actively recruits new graduates through student experience programs. The company's community responsibility program is highly regarded. Congratulations to these companies!

Survey participants were also asked to disclose what they like most and least about their jobs. Some common and unique responses are noted in the following sections.

Best aspects of jobs

"Challenging, demanding, and always new content."

"Human contact."

"Flexible schedule."

"Ability to mentor young technicians."

"Being in contact with peers around the world."

"Opportunity to meet high-level scientists."

"The products we make really do change people's lives."

"Scientific independence."

"My boss is 2500 miles away."

"Opportunity to deal with many different formulation challenges."

"Being on the forefront of technology."

"Spirit of enthusiasm."

"Salary increases."

"Location."

"Variety. You will not do the same thing year after year."

"Being recognized as an expert."

"The people."

"I control my pace and am able to stick to my eight hours a day."

"I get to see the entire industry as I conduct pharmaceutical inspections around the world."


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
14%
To select process for new products only
23%
To select processes for both new and legacy products
20%
Do not use QbD
25%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here